Insight Medicine - Medicine.net

INSIGHT Medicine(phase 43,2024)

Updated on: November 14,2024

0

INSIGHT Medicine(phase 43,2024)

Updated on:November 14,2024

0

An AI-driven computational platform for next-gen sweetener discovery

Updated on: October 22,2024

0

An AI-driven computational platform for next-gen sweetener discovery

Updated on:October 22,2024

0

Drexel's Oral Small Molecule GLP-1RA Phase IIb Clinical Study Completes First Dose Group Administration

Updated on: October 12,2024

0

Drexel's Oral Small Molecule GLP-1RA Phase IIb Clinical Study Completes First Dose Group Administration

Updated on:October 12,2024

0

Sci. Adv. | Dijun Chen's group develops a single-cell and spatial transcriptome-based method to identify spatial domains in tumor microenvironment

Updated on: October 09,2024

0

Sci. Adv. | Dijun Chen's group develops a single-cell and spatial transcriptome-based method to identify spatial domains in tumor microenvironment

Updated on:October 09,2024

0

INSIGHT medicine(phase 42,2024)HIV

Updated on: September 30,2024

0

INSIGHT medicine(phase 42,2024)HIV

Updated on:September 30,2024

0

INSIGHT of Medcine(phase 41,2024)SARS-CoV-2

Updated on: September 15,2024

0

INSIGHT of Medcine(phase 41,2024)SARS-CoV-2

Updated on:September 15,2024

0

Large Language Models in Drug Development: A Review by Harvard's George Church Lab

This article discusses the significant potential of LLMs in understanding disease mechanisms, drug discovery, and clinical trials—three fundamental stages of drug development. This article is authorized by the DrugAI team to medicine.net.

Updated on: September 15,2024

0

Large Language Models in Drug Development: A Review by Harvard's George Church Lab

This article discusses the significant potential of LLMs in understanding disease mechanisms, drug discovery, and clinical trials—three fundamental stages of drug development. This article is authorized by the DrugAI team to medicine.net.

Updated on:September 15,2024

0